Raymond James Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $123

Benzinga · 10/14 17:17
Raymond James analyst Jayson Bedford maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and lowers the price target from $128 to $123.